Trial Profile
Phase 1-2, prospective, randomised, double blind, placebo-controlled, dose escalation, parallel-group study to test the efficacy and safety of homatropine methylbromide oral suspension on selected climacteric symptoms and quality of life in menopausal women not receiving hormonal replacement therapy.
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 01 Sep 2012
Price :
$35
*
At a glance
- Drugs Homatropine methylbromide (Primary)
- Indications Hot flashes
- Focus Adverse reactions
- 01 Sep 2012 New trial record